Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy.
about
Neuropathic cancer pain: What we are dealing with? How to manage it?CXCR1/2 pathways in paclitaxel-induced neuropathic painCutaneous neuropathy in Parkinson's disease: a window into brain pathology.High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathyLocal and systemic cytokine expression in patients with postherpetic neuralgia.IL-4 deficiency is associated with mechanical hypersensitivity in mice.Small fibers in Fabry disease: baseline and follow-up data under enzyme replacement therapy.Skin cytokine expression in patients with fibromyalgia syndrome is not different from controlsSmall-fibre neuropathies--advances in diagnosis, pathophysiology and management.Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control studySkin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry Disease.Amplitudes of Pain-Related Evoked Potentials Are Useful to Detect Small Fiber Involvement in Painful Mixed Fiber Neuropathies in Addition to Quantitative Sensory Testing - An Electrophysiological Study.Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.Evaluating dermal myelinated nerve fibers in skin biopsy.Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot studyElevated IL-1β and IL-6 levels in lumbar herniated discs in patients with sciatic painOrgan manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y.Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trialARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density.Role of Expression of Inflammatory Mediators in Primary and Recurrent Lumbar Disc Herniation.A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.Utility of skin biopsy in management of small fiber neuropathy.Progress in the treatment of small fiber peripheral neuropathy.The Role and Importance of Small Fiber Neuropathy in Fibromyalgia Pain.Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.Exploring pain pathophysiology in patients.Cellular infiltrates in skin and sural nerve of patients with polyneuropathies.A prospective, observational study of patients with uncommon distal symmetric painful small-fiber neuropathy.Disruption of nodal architecture in skin biopsies of patients with demyelinating neuropathies.Small fibre pathology in patients with fibromyalgia syndrome.Evidence of abnormal epidermal nerve fiber density in fibromyalgia: clinical and immunologic implications.Nodes of Ranvier in skin biopsies of patients with diabetes mellitus.Analysis of myelinated fibers in human skin biopsies of patients with neuropathies.Nerve biopsy in chronic inflammatory neuropathies: in situ biomarkers.Capsaicin 8% patch reversibly reduces A-delta fiber evoked potential amplitudes.Probiotic DSF counteracts chemotherapy induced neuropathic pain.Mitochondrial loss indicates early axonal damage in small fiber neuropathies
P2860
Q26998945-DCB9F52C-77F6-4146-8D3B-8304DDE60A34Q33618624-8B934136-727E-497F-9151-504398A3B4BCQ33764504-1D230031-36A5-408A-8311-413956081D77Q33979446-E7261DC8-EF92-43CB-8AB2-4D38F26D1AECQ34051040-E0727353-AF1D-4D9B-BD89-85A5B1FDD5A9Q34099062-4748DA03-0E2A-4B47-A101-FDCCAFFE9C90Q34103791-B0E39D80-6DFA-4F8C-98D0-F6DBB08DA338Q34246455-21786FB9-6547-4DE7-B331-B26B8852BC58Q34277762-5D00EE9B-71A0-4999-A091-EB94A4ED5D29Q34739186-EB511287-D945-4F3B-8947-7483BC6BE81DQ36193984-7275DBA9-6046-43C3-9F35-A0869CBBC607Q36349888-9C12D9D2-5A71-458E-92F6-389FB83365E3Q36439933-D2D6C480-C52B-415F-BCF4-F69217D6616BQ36484556-CAC30110-035F-43F9-9800-090495718B2DQ36585607-2238CA80-EF67-4A71-A1AE-F572D672D336Q36780184-25F6CF58-ACC4-46EE-937A-14EF5C512EA0Q36819212-4842B997-EF4A-4FEC-92E7-679ABF4FC119Q37113332-48764089-B852-41E5-AA45-837DD460B0BAQ37446047-6B0C3BC8-EFED-4BDB-8AD7-3A2A97C0F455Q37576944-8C518363-37CB-49F3-9E68-AF38E6F6F33BQ37582203-8265CD13-55E7-4199-B0AE-FDF1DE286678Q38095866-092B346B-4FCF-41E3-8C2F-5FA2425ECA45Q38349089-056DAD55-CFB1-41C1-9898-AC96DFC1EF5CQ38615410-DEC754CF-ABC6-4CB0-9A49-0B379B6A586FQ38715136-A9391AD3-7DFF-47DC-9630-184DD9A19B9FQ38998012-B1D64DE7-F3E7-4E43-9562-3744569F7321Q39624953-7BF31FC1-2BB3-4985-BFF2-4DF388977B55Q42366171-B7FD6AF3-F8DE-4F37-A697-D3F44CDD6DF6Q44424031-6B2B7F23-EB35-4055-82E5-6011C0DC04CFQ45323620-101E6A70-E2DE-4661-B7D3-62320B6A15A0Q46056900-DC5DEF20-D67B-42B9-A14A-65ECE7AE442CQ50963135-26DF7CD4-DAB6-4CC9-BF69-C995F58F2737Q53669269-3B202600-09D2-461A-A0B0-064F21538E68Q54362178-45AFBF17-0F43-4140-996B-A3AC0FF2E816Q54962764-CD5FD329-549E-411D-ACBA-30CBE355D2C0Q55370630-B59D6F4D-3CC9-4C7C-8068-EE6026AB2119Q57913822-9595AA8D-07C5-444C-9335-7A8F4F99F195
P2860
Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy.
@en
Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy.
@nl
type
label
Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy.
@en
Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy.
@nl
prefLabel
Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy.
@en
Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy.
@nl
P2093
P1433
P1476
Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy.
@en
P2093
P304
P356
10.1212/WNL.0B013E3181E0F7B3
P407
P577
2010-06-01T00:00:00Z